LGR5 and colon carcinoma: Consistent with a prior study, we found that stage I colon carcinomas that expressed LGR5 (LGR5+; n= 10) significantly associated with the intestinal SC signature when compared to those that did not express LGR5 (LGR5−; n= 7) (Figure 1F and Supplemental Figure 1B) [21].